Loading...
Cerus Community
NasdaqGM:CERS Community- 1 Narratives written by author
- 0 Comments on narratives written by author
- 10 Fair Values set on narratives written by author
Community Investing Ideas
Aging Population And Regulatory Approvals Will Open New Markets
Key Takeaways Growing demand for blood safety and regulatory momentum are driving increased adoption of INTERCEPT products, supporting sustainable revenue and market share expansion. Shifting to a recurring revenue model with product innovation and geographic expansion boosts sales predictability and potential for higher margins.Read more
0users have liked this narrative
0users have commented on this narrative
9users have followed this narrative
AN
US$4.67
68.1% undervalued intrinsic discount
AnalystConsensusTarget Fair Value
Revenue growth
13.38% p.a.
Profit Margin
12.49%
Future PE
35.6x
Share price in 2028
US$5.92
